abstract |
In general, the present invention relates to the rano of tetracyclic terpenol as an anti-inflammatory, anticancer and analgesic agent, through the inhibition of the disordered activation of serine-threonine protein kinases, in particular PKC. It relates to the pharmaceutical use of the star-8,24-diene-3-ol population. |